to evaluate changes in the disposition of bevantolol produced by liver disease , a single 200-mg oral dose of bevantolol was administered in ten patients who had hepatic cirrhosis and to ten age-matched controls .
C0023895
liver disease
C0023890
hepatic cirrhosis